A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

NCT07193901 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD

Interventions

DRUG: Low Dose PRT042 nasal spray
DRUG: median Dose PRT042 nasal spray
DRUG: high dose PRT042 nasal spray
DRUG: placebo

Sponsor

Sichuan Purity Pharmaceutical Technology Co., Ltd.